← Open Payments lookup

DEBORAH PRICE: Open Payments

NPI 1124044573 · WENATCHEE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$269 in 12 payments from 7 companies in 2025. Trend: 2023 $377 · 2024 $132 · 2025 $269

Food & beverage: $269
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc2$80
Otsuka America Pharmaceutical, Inc.3$47
Teva Pharmaceuticals USA, Inc.2$47
ABBVIE INC.2$39
Neurocrine BioSciences, Inc.1$19
Axsome Therapeutics, Inc.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18

Products named: INVEGA SUSTENNA, UZEDY, VRAYLAR, ABILIFY ASIMTUFII, INGREZZA, Auvelity, CAPLYTA, REXULTI.

Industry payments across WA — which companies pay providers there.